DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending ...

The company anticipates continued volatility in bookings due to customer caution and reprioritizations. Elevated cancellation rates are expected to persist throughout 2025. Guidance for 2025 reflects ...

The most recent guidance for Icon (ICLR) was reported on October 22, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $13.00 to $13.20, compared to the ...

ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research organization said that it expects to report 2025 revenue of $8.05B to $8.650B, with ...

Icon delayed its fourth-quarter and 2025 financial results amid its ongoing accounting review, with preliminary findings suggesting the company's revenue for fiscal years 2023 and 2024 may have been ...

Earnings Call Insights: ICON Public Limited Company (ICLR) Q1 2025 The company anticipates continued volatility in bookings due to customer caution and reprioritizations. Elevated cancellation rates ...